433 related articles for article (PubMed ID: 27393904)
21. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; Perales C; Soria ME; García-Cehic D; Gregori J; Rodríguez-Frías F; Buti M; Crespo J; Calleja JL; Tabernero D; Vila M; Lázaro F; Rando-Segura A; Nieto-Aponte L; Llorens-Revull M; Cortese MF; Fernandez-Alonso I; Castellote J; Niubó J; Imaz A; Xiol X; Castells L; Riveiro-Barciela M; Llaneras J; Navarro J; Vargas-Blasco V; Augustin S; Conde I; Rubín Á; Prieto M; Torras X; Margall N; Forns X; Mariño Z; Lens S; Bonacci M; Pérez-Del-Pulgar S; Londoño MC; García-Buey ML; Sanz-Cameno P; Morillas R; Martró E; Saludes V; Masnou-Ridaura H; Salmerón J; Quíles R; Carrión JA; Forné M; Rosinach M; Fernández I; García-Samaniego J; Madejón A; Castillo-Grau P; López-Núñez C; Ferri MJ; Durández R; Sáez-Royuela F; Diago M; Gimeno C; Medina R; Buenestado J; Bernet A; Turnes J; Trigo-Daporta M; Hernández-Guerra M; Delgado-Blanco M; Cañizares A; Arenas JI; Gomez-Alonso MJ; Rodríguez M; Deig E; Olivé G; Río OD; Cabezas J; Quiñones I; Roget M; Montoliu S; García-Costa J; Force L; Blanch S; Miralbés M; López-de-Goicoechea MJ; García-Flores A; Saumoy M; Casanovas T; Baliellas C; Gilabert P; Martin-Cardona A; Roca R; Barenys M; Villaverde J; Salord S; Camps B; Silvan di Yacovo M; Ocaña I; Sauleda S; Bes M; Carbonell J; Vargas-Accarino E; Ruzo SP; Guerrero-Murillo M; Von Massow G; Costafreda MI; López RM; González-Moreno L; Real Y; Acero-Fernández D; Viroles S; Pamplona X; Cairó M; Ocete MD; Macías-Sánchez JF; Estébanez A; Quer JC; Mena-de-Cea Á; Otero A; Castro-Iglesias Á; Suárez F; Vázquez Á; Vieito D; López-Calvo S; Vázquez-Rodríguez P; Martínez-Cerezo FJ; Rodríguez R; Macenlle R; Cachero A; Mereish G; Mora-Moruny C; Fábregas S; Sacristán B; Albillos A; Sánchez-Ruano JJ; Baluja-Pino R; Fernández-Fernández J; González-Portela C; García-Martin C; Sánchez-Antolín G; Andrade RJ; Simón MA; Pascasio JM; Romero-Gómez M; Antonio Del-Campo J; Domingo E; Esteban R; Esteban JI; Quer J
Antiviral Res; 2020 Feb; 174():104694. PubMed ID: 31857134
[TBL] [Abstract][Full Text] [Related]
22. Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data.
Chen ZW; Li H; Ren H; Hu P
Sci Rep; 2016 Feb; 6():20310. PubMed ID: 26842909
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience.
Del Campo JA; Parra-Sánchez M; Figueruela B; García-Rey S; Quer J; Gregori J; Bernal S; Grande L; Palomares JC; Romero-Gómez M
Int J Infect Dis; 2018 Feb; 67():114-117. PubMed ID: 29253705
[TBL] [Abstract][Full Text] [Related]
24. Next-Generation Sequencing of 5' Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment.
Caraballo Cortes K; Bukowska-Ośko I; Pawełczyk A; Perlejewski K; Płoski R; Lechowicz U; Stawiński P; Demkow U; Laskus T; Radkowski M
Adv Exp Med Biol; 2016; 885():11-23. PubMed ID: 26747069
[TBL] [Abstract][Full Text] [Related]
25. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs.
Minosse C; Gruber CEM; Rueca M; Taibi C; Zaccarelli M; Grilli E; Montalbano M; Capobianchi MR; Antinori A; D'Offizi G; McPhee F; Garbuglia AR
Viruses; 2021 Jun; 13(6):. PubMed ID: 34208646
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of a Hepatitis C Virus whole-genome sequencing pipeline for genotyping and resistance testing.
Bradshaw D; Bibby DF; Manso CF; Piorkowska R; Mohamed H; Ledesma J; Bubba L; Chan YT; Ngui SL; Carne S; Mbisa JL;
Clin Microbiol Infect; 2022 Mar; 28(3):405-409. PubMed ID: 34245902
[TBL] [Abstract][Full Text] [Related]
27. Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.
Wang Y; Rao HY; Xie XW; Wei L
Chin Med J (Engl); 2015 Oct; 128(19):2625-31. PubMed ID: 26415801
[TBL] [Abstract][Full Text] [Related]
28. Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus.
Hedskog C; Chodavarapu K; Ku KS; Xu S; Martin R; Miller MD; Mo H; Svarovskaia E
J Clin Microbiol; 2015 Jul; 53(7):2049-59. PubMed ID: 25878342
[TBL] [Abstract][Full Text] [Related]
29. Validation of a Genotype-Independent Hepatitis C Virus Near-Whole Genome Sequencing Assay.
Lapointe HR; Dong W; Dong WWY; Kirkby D; Woods C; Poon AFY; Howe AYM; Harrigan PR; Brumme CJ
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578305
[TBL] [Abstract][Full Text] [Related]
30. A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus.
Pedersen MS; Fahnøe U; Hansen TA; Pedersen AG; Jenssen H; Bukh J; Schønning K
J Clin Virol; 2018 Aug; 105():49-56. PubMed ID: 29886373
[TBL] [Abstract][Full Text] [Related]
31. Whole-genome sequencing of human Pegivirus variant from an Egyptian patient co-infected with hepatitis C virus: a case report.
Soliman HK; Abouelhoda M; El Rouby MN; Ahmed OS; Esmat G; Hassan ZK; Hafez MM; Mehaney DA; Selvaraju M; Darwish RK; Osman YA; Zekri AN
Virol J; 2019 Nov; 16(1):132. PubMed ID: 31711510
[TBL] [Abstract][Full Text] [Related]
32. Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1b.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Med Virol; 2014 Aug; 86(8):1314-22. PubMed ID: 24797623
[TBL] [Abstract][Full Text] [Related]
33. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges.
Trémeaux P; Caporossi A; Thélu MA; Blum M; Leroy V; Morand P; Larrat S
Crit Rev Clin Lab Sci; 2016 Oct; 53(5):341-51. PubMed ID: 27068766
[TBL] [Abstract][Full Text] [Related]
35. Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches.
de Carvalho IM; Alves R; de Souza PA; da Silva EF; Mazo D; Carrilho FJ; Queiroz AT; Pessoa MG
J Med Virol; 2014 Oct; 86(10):1714-21. PubMed ID: 25042789
[TBL] [Abstract][Full Text] [Related]
36. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.
Quer J; Gregori J; Rodríguez-Frias F; Buti M; Madejon A; Perez-del-Pulgar S; Garcia-Cehic D; Casillas R; Blasi M; Homs M; Tabernero D; Alvarez-Tejado M; Muñoz JM; Cubero M; Caballero A; del Campo JA; Domingo E; Belmonte I; Nieto L; Lens S; Muñoz-de-Rueda P; Sanz-Cameno P; Sauleda S; Bes M; Gomez J; Briones C; Perales C; Sheldon J; Castells L; Viladomiu L; Salmeron J; Ruiz-Extremera A; Quiles-Pérez R; Moreno-Otero R; López-Rodríguez R; Allende H; Romero-Gómez M; Guardia J; Esteban R; Garcia-Samaniego J; Forns X; Esteban JI
J Clin Microbiol; 2015 Jan; 53(1):219-26. PubMed ID: 25378574
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus resistance to the new direct-acting antivirals.
Esposito I; Trinks J; Soriano V
Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1197-209. PubMed ID: 27384079
[TBL] [Abstract][Full Text] [Related]
38. Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants.
Newman RM; Kuntzen T; Weiner B; Berical A; Charlebois P; Kuiken C; Murphy DG; Simmonds P; Bennett P; Lennon NJ; Birren BW; Zody MC; Allen TM; Henn MR
J Infect Dis; 2013 Jul; 208(1):17-31. PubMed ID: 23136221
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing for the clinical management of hepatitis C virus infections: does one test fits all purposes?
Cuypers L; Thijssen M; Shakibzadeh A; Sabahi F; Ravanshad M; Pourkarim MR
Crit Rev Clin Lab Sci; 2019 Sep; 56(6):420-434. PubMed ID: 31317801
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
May S; Adamska E; Tang J
J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
